Bausch Health Companies Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BHC New York 2834 www.bauschhealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bausch Health Companies Inc.

Bausch Health to Announce Second Quarter 2025 Results on July 30 - Jul 2nd, 2025 5:00 am
Marriott Vacations, Bausch Health See Activist Actions - Jun 27th, 2025 5:03 pm
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June - Jun 23rd, 2025 9:58 am
A Billionaire Trump Supporter Is Buying These Two Stocks - Jun 22nd, 2025 3:00 am
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Jun 14th, 2025 7:07 am
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - Jun 10th, 2025 6:54 am
Why Is Bausch (BHC) Down 13% Since Last Earnings Report? - May 30th, 2025 9:31 am
With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - May 29th, 2025 4:33 am
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - May 27th, 2025 10:47 am
3 Reasons to Avoid BLCO and 1 Stock to Buy Instead - May 21st, 2025 10:00 pm
Bausch Health Announces 2025 Annual Meeting of Shareholder Results - May 14th, 2025 2:15 pm
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty - May 14th, 2025 4:36 am
New Strong Sell Stocks for May 13th - May 13th, 2025 4:28 am
Bausch + Lomb receives CE mark for Luxlife intraocular lens - May 9th, 2025 3:00 am
Bausch + Lomb gains CE Mark approval for full range of vision intraocular lens - May 8th, 2025 3:29 am
Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - May 7th, 2025 6:45 am
Bausch Health Up 3.5% In US Premarket As Says New Analysis Suggests efficacy of Xifaxan - May 6th, 2025 6:28 am
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization - May 6th, 2025 6:00 am
Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations - May 2nd, 2025 4:10 am
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - May 1st, 2025 7:48 am